Narrative Review and Evidence Mapping

Proteomics for Cancer and Cardiovascular Disease

Published in: Patient-Centered Outcomes Research Institute website (2021)

Posted on on August 26, 2021

by Patricia Ann Stapleton, Sameer M. Siddiqi, Eric Apaydin, Goke Akinniranye, Alejandro U. Becerra-Ornelas, Grace Gahlon, Lea Xenakis, Max Griswold, Jody Larkin

Full Document

FormatFile SizeNotes
PDF file 1.8 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Read More

Access further information on this document at

This article was published outside of RAND. The full text of the article can be found at the link above.

Proteomics involves the identification and quantification of all or specific proteins in a biological sample, with the purpose of explaining the structure and function of those proteins in an organism. Clinical proteomics offers the promise of more precise risk assessment, diagnosis, and prognosis of disease. As such, proteomic testing has been proposed for a wide variety of applications, including for determining risk of conditions, diagnosing conditions, helping select optimal therapies, and determining response to therapies. Because of increased attention to the potential of proteomic testing, the Patient-Centered Outcomes Research Institute (PCORI) commissioned a narrative review and the development of evidence maps regarding these procedures. Evidence maps provide a visual overview of large research areas by indicating the research focus and the quantity of existing research as well as gaps in knowledge. This report presents, in an evidence map format, the evidence currently supporting approved proteomic tests in the United States for cancer and cardiovascular disease, as well as proteomic tests in these medical fields that may be available in the near term.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.